Improving Ischemic Outcomes in ACS: Lessons and Case Discussions from the Experts is organized by C3-Interventional Academy.

Release Date: Nov 01, 2019
Expiration Date: Dec 31, 2019

Target Audience:
This activity is designed for attendees of C3 Annual Meeting and other clinicians: interventional cardiologists, cardiologists, vascular surgeons, cardiothoracic surgeons, primary care physicians, technologists and nurses who mange thrombotic risks across diverse patient populations.

Accreditation:
Ciné-Med designates this enduring material for a maximum of 2 AMA PRA Category 1Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Educational Objectives:
Upon completion of this activity learners should be able to:
• Discuss the latest guidelines for antiplatelet therapy in ACS
• Describe the impact of oral antiplatelet therapy on Cardiovascular Mortality in ACS
• Outline the latest efficacy and safety data of antiplatelet therapies for patients undergoing PCI
• Explore the advantages and challenges of maintaining longer term antiplatelet therapy for reduction of cardiovascular risk

Additional details will be posted as soon as information is available.